Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of pharmaceuticals, Biotechnology and a chain of advanced Super Specialty Hospitals.
Company had incurred loss in year 2009 & 2010 on account of leverage overseas acquisition along with foreign exchange and derivatives losses. Post debt recast, company has come out with vibrant financial results
Consolidated yearly financials
Consolidated quarterly financials
Peer company valuation comparison based on Jun-12 quarter results
Minor correction in price is expected in next couple of days. Buy with long term investment objective.
Disclaimer:
Company had incurred loss in year 2009 & 2010 on account of leverage overseas acquisition along with foreign exchange and derivatives losses. Post debt recast, company has come out with vibrant financial results
Consolidated yearly financials
Consolidated quarterly financials
Peer company valuation comparison based on Jun-12 quarter results
Minor correction in price is expected in next couple of days. Buy with long term investment objective.
Disclaimer:
Any purchase/sale of a stock involves a high degree of investment risk. Caution all investors that they may lose some or all of their investment if they decide to purchase any stock listed here.
No comments:
Post a Comment
Comments